English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Beetroot supplement increases nitric oxide markers in triathletes after one week, study finds
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Researchers find APOE4 gene affects bone quality in female mice
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Study finds minimal academic impact from prenatal opioid exposure after controlling for environment
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Barnsley audiologist Rebecca Jenkins to run London Marathon for Hearing Dogs charity
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

BioSpace leaders discuss Q1 2026 job market trends and outlook
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Eli Lilly acquires CrossBridge Bio in $300 million deal for cancer drug development
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

FDA urges over 2,200 drug developers to publish clinical trial results
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

FDA approves Filspari as first treatment for rare kidney disease FSGS

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones